Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-04 07:48 am Sale | 2026-10-31 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 0 0.000% | -124,135 (Position Closed) | Filing History |
| 2026-10-07 07:18 am Sale | 2026-09-30 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 124,135 5.060% | -88,607 (-41.65%) | Filing History |
| 2026-08-06 10:14 am Sale | 2026-06-30 | 13G | ATYR PHARMA INC ATYR | FMR LLC | 61,785 2.500% | -86,613 (-58.37%) | Filing History |
| 2026-07-27 4:25 pm Sale | 2026-06-30 | 13G | ATYR PHARMA INC ATYR | BlackRock Inc. BLK | 43,127 1.800% | -100,963 (-70.07%) | Filing History |
| 2026-07-08 07:37 am Sale | 2026-06-30 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 212,742 8.680% | -50,869 (-19.30%) | Filing History |
| 2026-06-05 10:13 am Sale | 2026-05-29 | 13G | ATYR PHARMA INC ATYR | FMR LLC | 148,398 6.100% | -71,202 (-32.42%) | Filing History |
| 2026-03-26 4:08 pm Sale | 2026-03-13 | 13G | ATYR PHARMA INC ATYR | VANGUARD GROUP INC | 0 0.000% | -116,376 (Position Closed) | Filing History |
| 2025-10-07 11:03 am Sale | 2025-09-30 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 263,611 10.760% | -103,054 (-28.11%) | Filing History |
| 2025-07-29 11:24 am Purchase | 2025-06-30 | 13G | ATYR PHARMA INC ATYR | VANGUARD GROUP INC | 116,376 5.230% | 116,376 (New Position) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | ATYR PHARMA INC ATYR | BlackRock Inc. BLK | 144,090 6.500% | 144,090 (New Position) | Filing History |
| 2025-05-15 3:55 pm Sale | 2025-03-31 | 13G | ATYR PHARMA INC ATYR | Point72 Asset Management, L.P. | 71,134 3.200% | -54,862 (-43.54%) | Filing History |
| 2025-01-08 1:38 pm Unchanged | 2024-12-31 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 366,665 17.470% | 0 (Unchanged) | Filing History |
| 2024-11-14 6:51 pm Sale | 2024-09-30 | 13G | ATYR PHARMA INC ATYR | Logos Global Management LP | 43,750 2.100% | -101,250 (-69.83%) | Filing History |
| 2024-10-15 5:01 pm Purchase | 2024-10-14 | 13G | ATYR PHARMA INC ATYR | Point72 Asset Management, L.P. | 125,996 6.200% | 125,996 (New Position) | Filing History |
| 2024-10-07 1:36 pm Purchase | 2024-09-30 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 366,665 19.350% | 112,425 (+44.22%) | Filing History |
| 2024-02-14 1:43 pm Sale | 2023-12-31 | 13G | ATYR PHARMA INC ATYR | Laurence W. Lytton | 14,625 1.000% | -96,380 (-86.82%) | Filing History |
| 2024-02-13 4:30 pm Sale | 2023-12-31 | 13G | ATYR PHARMA INC ATYR | Stonepine Capital Management LLC | 12,056 0.800% | -106,523 (-89.83%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | ATYR PHARMA INC ATYR | FMR LLC | 219,600 14.999% | 110,815 (+101.87%) | Filing History |
| 2024-01-18 10:17 am Purchase | 2023-12-31 | 13G | ATYR PHARMA INC ATYR | FEDERATED HERMES INC. FHI | 254,240 17.370% | 123,450 (+94.39%) | Filing History |
| 2024-01-02 12:21 pm Purchase | 2023-12-19 | 13G | ATYR PHARMA INC ATYR | Logos Global Management LP | 145,000 9.900% | 145,000 (New Position) | Filing History |